Withagulatin A inhibits hepatic stellate cell viability and procollagen I production through Akt and Smad signaling pathways.

Acta Pharmacologica Sinica
Qiong LiuXu Shen

Abstract

To investigate the effects of the natural product Withagulatin A on hepatic stellate cell (HSC) viability and type I procollagen production. The potential mechanism underlying the pharmacological actions was also explored. The effect of Withagulatin A on cell viability was evaluated in HSC and LX-2 cells using a sulforhodamine B (SRB) assay. Cell cycle distribution was analyzed using flow cytometry. Type I procollagen gene expression was determined using real-time PCR. Regulation of signaling molecules by Withagulatin A was detected using Western blotting. Primary rat HSCs and the human hepatic stellate cell line LX-2 treated with Withagulatin A (0.625-20 micromol/L) underwent a dose-dependent decrease in cell viability, which was associated with S phase arrest and the induction of cell apoptosis. In addition, the natural product decreased phosphorylation of the Akt/mTOR/p70S6K pathway that controls cell proliferation and survival. Furthermore, Withagulatin A (1, 2 mumol/L) inhibited transforming growth factor-beta (TGF-beta) stimulated type I procollagen gene expression, which was attributable to the suppression of TGF-beta stimulated Smad2 and Smad3 phosphorylation. Our results demonstrated that Withagulatin A potently inhibi...Continue Reading

References

Jan 1, 1992·The American Journal of Chinese Medicine·Y S LinM H Won
Jan 1, 1992·Annual Review of Biochemistry·C Norbury, P Nurse
Aug 1, 1991·Natural Product Reports·E Glotter
Jul 4, 1990·Journal of the National Cancer Institute·P SkehanM R Boyd
Dec 6, 1996·Science·B Stillman
Jun 23, 1997·FEBS Letters·N Pullen, G Thomas
Jan 1, 1997·Annual Review of Cell and Developmental Biology·D O Morgan
May 23, 1998·Annual Review of Immunology·D T Chao, S J Korsmeyer
Aug 28, 1998·Science·N A Thornberry, Y Lazebnik
Jan 25, 2000·The Journal of Biological Chemistry·S L Friedman
Jun 2, 2001·Clinics in Liver Disease·E Albanis, S L Friedman
Oct 5, 2001·Nature Reviews. Molecular Cell Biology·M P Scheid, J R Woodgett
Aug 26, 2003·Journal of Cellular Biochemistry·Kenneth R Cutroneo
Oct 9, 2004·Annual Review of Pharmacology and Toxicology·Sophie LotersztajnAriane Mallat
Jan 29, 2005·The Journal of Biological Chemistry·Erwin GäbeleRichard A Rippe
Feb 4, 2005·The Journal of Clinical Investigation·Ramón Bataller, David A Brenner
Apr 21, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sören V SiegmundRobert F Schwabe
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Scott L Friedman, Meena B Bansal
Apr 11, 2006·Molecular Cell·Dos D SarbassovDavid M Sabatini
Mar 21, 2007·Chemistry & Biodiversity·Qing-Ping HeLi-Hong Hu
May 13, 2008·Gastroenterology·Scott L Friedman
Jan 27, 2009·Cellular Signalling·Regan M Memmott, Phillip A Dennis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis